semaglutide legal Novo Nordisk takes action over copycat Ozempic medication FDA free to pursue semaglutide

Semaglutide works by mimicking a hormone (glucagon-like peptide-1 [GLP-1]) that targets the areas of the brain regulating appetite

The medication contains the same active ingredient as injectable Wegovy but in a once-daily pill formulation , potentially expanding the eligible patient population to include individuals who have previously avoided injection-based treatments

For example, a nutritionist is well positioned to educate the patient on the potential for malnutrition, and in the event the patient desires to continue the GLP-1 RA, how that decision may unfold

Nausea affects approximately 39% of users

By improving insulin secretion and reducing glucose production, it helps maintain better glycemic control, reducing the likelihood of diabetes-related complications